Embecta Corp (EMBC)
Return on total capital
| Sep 30, 2023 | Sep 30, 2022 | ||
|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 221,500 | 309,600 |
| Long-term debt | US$ in thousands | 1,593,900 | 1,598,100 |
| Total stockholders’ equity | US$ in thousands | -821,700 | -891,400 |
| Return on total capital | 28.68% | 43.81% |
September 30, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $221,500K ÷ ($1,593,900K + $-821,700K)
= 28.68%
Peer comparison
Sep 30, 2023
Company name
Symbol
Return on total capital
Embecta Corp
EMBC
28.68%
3M Company
MMM
-48.86%
Artivion Inc
AORT
0.63%
Baxter International Inc
BAX
37.30%
Becton Dickinson and Company
BDX
5.10%
Boston Scientific Corp
BSX
12.15%
DexCom Inc
DXCM
16.23%
Glaukos Corp
GKOS
-16.13%
Globus Medical
GMED
3.02%
Haemonetics Corporation
HAE
9.38%
ICU Medical Inc
ICUI
0.66%